Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0000899243-21-036432

Chief Operating Officer acquired 8,501 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bensen Daniel Chief Operating Officer 2021-09-17 Conversion +8,501 527,981 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bensen Daniel Chief Operating Officer 2021-09-17 Conversion · Series A Preferred Stock −3,273 0 D: show line 2 in the form
Loading xslF345X03/doc4.xml…